Micro/Nanoplastics Drive Amyloid‑β Colloidal and Oxidative Reorganization: A Real-World Contaminant Stressor Authors: Hasan Saygin, Asli Baysal, Emre Apaydin, Pemra Ozbek Published: 2026 ABSTRACT Environmental micro- and nanoplastics (MNPs) are increasingly recognized as biologically active particulate contaminants, yet their influence on amyloid-beta (Aβ) structural behavior and oxidative chemistry remains insufficiently defined. In this study, consumer-derived polyethylene terephthalate (PET) MNPs were used as a real-world contaminant model to evaluate time-dependent interactions with Aβ at subagglomeration peptide concentrations. Aβ solutions (0.1–1000 pg/mL) were exposed to PET MNPs (10, 40, and 100 μg/mL) for 1–144 h and assessed using fluorescence spectroscopy, apparent Stern–Volmer-type analysis, turbidity, Rayleigh light scattering (RLS), zeta potential, dynamic light scattering (DLS), FTIR, Raman spectroscopy, UV–Vis slope factor analysis, cell-free dithiothreitol oxidative potential, and molecular docking. PET MNP exposure produced wavelength-, concentration-, dose-, and time-dependent fluorescence modulation. Apparent Stern–Volmer slopes were small and bidirectional rather than uniformly positive, indicating nonclassical fluorescence behavior rather than a single dynamic quenching or binding mechanism. Turbidity and RLS increased mainly during early exposure, suggesting formation of light-scattering Aβ–MNP-associated assemblies, whereas prolonged exposure was associated with reduced scattering signals, nanoscale DLS profiles, and fluctuating zeta potentials, indicating a change in the abundance or scattering behavior of species remaining in the measured postfiltration phase. The available data cannot distinguish interfacial reorganization from microsedimentation, localized precipitation, nonspecific vessel-wall adsorption, filtration-sensitive loss, or altered scattering efficiency. FTIR and Raman results indicated changes in Amide II/III, C–O/C–H, and aromatic-residue-associated regions, while DTT results showed modest but measurable enhancement of cell-free oxidative potential. Docking simulations suggested possible PET–Aβ contacts involving aggregation-prone aromatic and polar residues, providing mechanistic support for interfacial association. Overall, PET MNPs are best interpreted as dynamic modulators of Aβ colloidal, structural, and oxidative behavior, initially favoring Aβ–MNP association and followed by later changes in the nanoscale, spectroscopic, and optical characteristics of the measured phase, without establishing a specific aggregate morphology or late-stage mechanism. Introduction Neurodegenerative diseases, including Alzheimer’s disease (AD), Parkinson’s disease (PD), and other chronic neurodegenerative disorders, affect millions of people worldwide. , Among the molecular features associated with AD, amyloid-beta (Aβ) misfolding, oligomerization, fibril formation, plaque deposition, oxidative stress, tau hyperphosphorylation, and neuroinflammatory processes are considered central components of disease progression. , Although Aβ aggregation and oxidative modification have been extensively investigated, the environmental factors that may modulate these processes remain incompletely understood. Increasing evidence links environmental contaminants, including airborne particulate matter, diesel exhaust particles, engineered nanoparticles, and other nanoscale materials, with neurodegenerative outcomes through oxidative stress, inflammation, mitochondrial dysfunction, neuronal injury, and altered protein homeostasis. − Plastic waste has become a persistent environmental and biological concern because it fragments into micro- and nanoplastics (MNPs). These particles may enter the human body through inhalation, ingestion, and other exposure routes and have been detected in multiple biological matrices. − The toxicological literature suggests that MNPs can induce oxidative stress, inflammatory responses, acetylcholinesterase inhibition, mitochondrial dysfunction, and membrane or protein-level perturbations, although many studies have focused on pristine polystyrene particles under simplified laboratory conditions. , Consequently, the behavior of consumer-derived or environmentally transformed plastic particles remains less well characterized, despite their greater relevance to realistic exposure scenarios. − The interaction between MNPs and proteins is particularly important because particle surfaces can adsorb biomolecules, alter local concentration gradients, modify electrostatic stability, and generate heterogeneous interfacial microenvironments. For amyloidogenic peptides, it is useful to distinguish between intrinsic aggregation and particle-mediated agglomeration. Aggregation refers to Aβ–Aβ self-association processes that may lead to oligomeric or fibrillar assemblies through intermolecular β-sheet interactions. , Agglomeration, in contrast, describes reversible heteroassociation or clustering involving Aβ–MNP and/or MNP–MNP assemblies mediated by peptide adsorption at particle interfaces. This distinction is important because optical scattering, fluorescence, and size-distribution measurements can indicate association or reorganization of Aβ-containing assemblies without directly proving mature fibril formation. In addition to physical interfacial effects, MNPs may modify the chemical environment of biomolecules. , Polyethylene terephthalate (PET) and other plastic particles can undergo physicochemical alteration in biological or protein-containing media and may release dissolved organic constituents or surface-associated functional groups into the surrounding solution. − Previous work has shown that PET MNPs can undergo deformation in protein-containing systems, including bovine serum albumin solutions, with evidence of polymer-chain-associated group release and spectral modification. Other studies have reported dissolved organic carbon release and oxidative activity from MNP-containing systems under environmental or biologically relevant conditions. − These findings suggest that MNPs may influence Aβ not only as passive surfaces but also as chemically active interfacial stressors capable of contributing to oxidative and conformational changes. Spectroscopic and colloidal methods are current and complementary tools for evaluating Aβ–particle interactions. − Fluorescence tracks changes in aromatic residue environments and interaction-related emission, while turbidity, RLS, zeta potential, and DLS describe light-scattering assemblies, colloidal stability, and apparent hydrodynamic size. , Because heterogeneous Aβ–MNP systems may show both fluorescence enhancement and suppression, apparent Stern–Volmer slopes should be treated as empirical fluorescence-modulation descriptors rather than direct binding or classical quenching constants. FTIR and Raman further support structural interpretation by probing peptide backbone, hydrogen-bonding, functional group, and aromatic-residue-associated vibrational changes. , Here, we investigated the effects of real-world PET MNPs on the colloidal, structural, fluorescence, oxidative, and interfacial behavior of Aβ under controlled in vitro conditions. Aβ was tested at ultralow concentrations selected to minimize spontaneous self-aggregation, and PET MNPs were applied at reproducible low-, intermediate-, and high-dose conditions. The study integrated fluorescence intensity ratios, apparent Stern–Volmer-type analysis, turbidity, RLS, zeta potential, DLS, FTIR, Raman spectroscopy, UV–Vis slope factor analysis, cell-free DTT oxidative potential, and molecular docking. Rather than treating the system as a formal kinetic model or a classical fluorescence-quenching/binding system, the data were interpreted as time-dependent, multiparameter evidence of Aβ–PET MNP interaction. The central aim was to determine whether PET MNPs act as dynamic modulators of Aβ colloidal and structural behavior, producing early Aβ–MNP association followed by time-dependent changes in the abundance, distribution, and spectroscopic characteristics of species remaining in the measured phase. Experimental Section Materials β-Amyloid (1–42) (Aβ1–42, human catalog number RP10017) was purchased from GenScript. MNPs were obtained using a “real-world approach” from PET water bottles, as explained by our previous studies. , The PET MNPs were characterized in detail, and the characterization results were previously presented in the study by Baysal et al. , (Figure S1). The size distribution results showed that particle sizes ranged from 270 to 500 nm, which is consistent with MNPs detected in the human body, such as the heart, placenta, lung, stool, and feces. ,, Exposure Procedure Aβ was dissolved in the phosphate buffer (PBS) at pH 7.4 to a final concentration of 1 mg/mL and ultrasonicated for 2 h. Then, various subconcentrations (0.1–1000 pg/mL) of freshly prepared Aβ solutions were used in all experiments. Here, the concentrations of Aβ were much lower than the critical aggregation concentration. These concentrations were selected to minimize spontaneous self-aggregation and to emphasize MNP-driven changes relative to time-matched Aβ controls. ,,,− A preliminary lower-dose condition (0.1 μg/mL PET MNPs) was also tested before establishing the final experimental matrix. Because this concentration produced highly variable responses with high RSD values and signals that were largely indistinguishable from the corresponding controls, it was excluded from the final data set. Accordingly, 10, 40, and 100 μg/mL PET MNPs were selected as reproducible low-, intermediate-, and high-dose conditions for subsequent time-dependent experiments. These doses were selected as a controlled in vitro exposure window rather than as direct physiological equivalents. This range overlaps with recent MNP–Aβ experimental studies using PET and other polymers at approximately 10–100 μg/mL and allows low-, intermediate-, and high-dose comparison of Aβ–MNP interactions. Human biomonitoring data further support the need to consider both systemic and localized exposure scenarios. For example, plastic particles have been reported in human blood at approximately 1.8–4.7 μg/mL, whereas a recent analysis of decedent frontal cortex tissue reported median MNP concentrations of 3345 μg/g in 2016 brain samples and 4917 μg/g in 2024 brain samples, with an interquartile range of 1267–5213 μg/g and 4026–5608 μg/g, respectively. Dementia-associated brain samples showed still higher median values of 26,076 μg/g, although these data are associative and do not establish causality. , Therefore, the present 10–100 μg/mL dose range should be interpreted as an experimentally justified in vitro screening range, contextualized by reported systemic detection and localized tissue accumulation, but not as a direct conversion of brain tissue burden into exposure-medium concentration. Furthermore, this 10–100 μg/mL range aligns with established in vitro neurotoxicity benchmarks, , providing a standardized and highly conservative toxicological window to assess dose-responsive structural and biochemical alterations without inducing nonspecific artifacts. , Three doses of MNPs (10, 40, and 100 μg/mL) were added to each subconcentration of Aβ solutions, and the mixtures were treated at 35 °C for 1 to 144 h horizontally in an incubator with a stirrer. After being kept in a horizontal shaker incubator to ensure homogeneous mixing of the plastic and Aβ solutions, the particles settled easily during the filtration process; they were carefully transferred to a syringe filter using a pipetting method, and great care was taken to prevent errors caused by particle contamination. After each incubation stage, PET MNPs were removed from the suspension prior to optical measurements using a 0.2 μm syringe membrane filter. The initial PET MNP size distribution ranged from 270 to 500 nm; therefore, the 0.2 μm membrane was expected to retain most particles within the original measured size range. To further reduce the potential carryover of particles into the filtration, the suspensions were allowed to settle before filtration. Due to the density difference between PET (1.38 g cm–3) and the PBS (∼1.001 g cm–3), PET particles preferentially sediment after incubation. The supernatant was therefore carefully collected and subsequently filtered. The efficiency of the separation step was evaluated using gravimetric recovery measurements of PET particles before addition and after incubation and separation, which yielded recovery values between ∼83.0% and 97.3%, depending on the exposure conditions (Table S1). Gravimetric measurements were performed by weighing residues before and after incubation/filtration using an analytical balance (Precise, ±0.00001 g). Gravimetric loss (%) was calculated as [(W initial–W recovered)/W initial]×100. Recovery (%) was calculated as 100-loss (%) and independently verified as (W recovered/W initial)×100. These results confirm that most PET particles were removed before spectroscopic measurements. To account for potential peptide loss due to nonspecific binding to the membrane filter, the Aβ controls without MNPs were prepared for each exposure duration and Aβ concentration. The resulting sample/control ratio thus isolates the specific effect of PET-mediated sequestration or spectral modification from baseline filtration artifacts. Reagent blank correction was also performed for both Aβ treated with and without MNP. The study was conducted with 3 repetitions and 3 analysis repetitions. Fluorescence Measurements Fluorescence measurements were performed using a microplate multispectrometer (Agilent Technologies, Australia; Varioskan LUX, Thermo Scientific). Because the selected Aβ concentrations were below the critical aggregation concentration, additional excitation (Ex)–emission (Em) combinations were examined to monitor intrinsic protein fluorescence and aggregation-related signals. Aromatic amino acid fluorescence and aggregate autofluorescence were monitored at Ex 215 nm/Em 310 nm (tyrosine); Ex 220 nm/Em 287 nm (phenylalanine (Phe)-related signal and tyrosine (Tyr10) may also contribute to this region); Ex 350 nm/Em 435 nm (aggregate-associated or environment-sensitive autofluorescence). These measurements enabled evaluation of conformational and aggregation-related changes in Aβ during interaction with MNPs. − Additional spectra were acquired using an excitation wavelength of 412 nm, with emission collected from 490 to 570 nm using a spectral slit width of 5 nm following the previously reported approach. This region was monitored to assess exposure-associated changes in long-wavelength fluorescence. The experiments were conducted in PBS, which has negligible intrinsic fluorescence in the monitored spectral regions. Moreover, blank correction/subtraction was applied. Crucially, all experiments were conducted at ultralow Aβ concentrations (0.1–1000 pg/mL), , which minimizes the potential for self-absorption and mitigates the inner-filter effect (IFE) that can frequently confound fluorescence readouts in highly concentrated or scattering protein solutions. Additionally, blank (Aβ-free) samples without Aβ produced negligible intrinsic fluorescence at these excitation and emission settings. Therefore, the recorded fluorescence signals predominantly originate from Aβ and its structural or chemical modifications. As mentioned above, to minimize optical interference from particulates, samples were allowed to sediment after incubation, and supernatants were carefully collected and filtered before fluorescence measurements. This procedure reduced potential contributions from residual particles and light scattering effects. Fluorescence results were expressed as the ratio of the fluorescence intensity of Aβ treated with MNPs (F) to that of untreated Aβ (control, F 0), allowing normalization of the signal and facilitating comparison of relative fluorescence changes induced by MNP exposure. In addition, the use of fluorescence intensity ratios (F/F 0) minimized potential variations related to optical path length, background fluorescence, and instrumental variability. Fluorescence measurements were performed at multiple incubation time points (1, 4, 24, 48, and 144 h) to monitor time-dependent structural and aggregation-related changes in Aβ. To further describe dose-dependent fluorescence modulation, apparent Stern–Volmer-type slopes were calculated for each excitation/emission condition, Aβ concentration, and exposure duration. For each condition, F 0 represents the fluorescence intensity of the time-matched Aβ control and F represents the fluorescence intensity of Aβ exposed to PET MNPs. The relationship between fluorescence response and PET MNP concentration was evaluated using 1 F0F=Ksv,app[Q]+1 where Ksv,app is the apparent Stern–Volmer slope and [Q] is the PET MNP concentration expressed as μg/mL. Because the fluorescence response included both signal enhancement and suppression depending on wavelength, Aβ concentration, MNP dose, and exposure duration, the obtained slopes were interpreted as empirical descriptors of dose-dependent fluorescence modulation rather than as classical dynamic quenching constants. Therefore, binding constants, binding-site numbers, and bimolecular quenching rate constants were not derived from these data. Rayleigh Scattering Measurements Rayleigh scattering (RLS) measurements to examine Aβ aggregation and particle-mediated clustering were performed at 25 ± 0.1 °C using a fluorescent microplate multispectrometer (Agilent Technologies, Australia). Aβ samples were excited at 350 nm, and spectra were recorded in the range of 300–400 nm. The data were presented in eq after being plotted at 350/350 nm, where RLS is the fluorescence intensity of Aβ treated with MNPs and RLS0 is the fluorescence intensity of Aβ treated without MNPs (control). 2 RLSRLS0=RLSofAβtreatedwithMNPsRLSofAβtreatedwithoutMNPs(control) Turbidity Measurements The turbidity of the Aβ samples, both treated and untreated, was monitored by measuring the absorbance at 660 nm using a Thermo Scientific (Skyhigh) microplate reader spectrometer in turbidity mode. , The measurements were carried out at 25 °C. The data are presented as the ratio of the turbidity of Aβ treated with MNPs (T) to the turbidity of Aβ treated without MNPs (control, T0), as explained in eq . 3 TT0=TurbidityofAβtreatedwithMNPsTurbidityofAβtreatedwithoutMNPs(control) Zeta Potential Measurements Zeta potentials and particle size distribution of Aβ in the presence and absence of MNPs were measured after the filtration of each incubation using a Zetasizer Nano ZS, Malvern, UK. Measurements were made in the PBS at pH 7.4 at 25 °C. Oxidative Potential Measurements The oxidative potential (OP) of the Aβ samples, with and without MNP treatment, was determined using a cell-free dithiothreitol (DTT) assay. Briefly, the OP was determined by measuring the consumption of DTT by incubating the MNP-treated and untreated Aβ in a phosphate buffer containing 1 mM DTT at 37 °C. DTNB was then added to react with the remaining DTT, and absorbance was measured at 412 nm using a UV–vis spectrometer. The data are presented as the ratio of DTT consumption in Aβ treated with MNPs (DTT) to DTT consumption in Aβ without MNPs (DTT0), as shown in eq . 4 DTTDTT0=DTTofAβtreatedwithMNPsDTTofAβtreatedwithoutMNPs(control) Fourier Transform Infrared Spectra and Raman Measurements FTIR spectra of Aβ samples were recorded in the presence and absence of MNP treatments, using a diamond ATR-FTIR spectrometer (Bruker, InvenioS). The absorption spectral range was collected between 400 cm–1 and 4000 cm–1, with a spectral resolution of 4 cm–1. Amide regions (Amide I, Amide II, and Amide III) for Aβ structural analysis were spanned from 1200 to 1700 cm–1. A semiquantitative analysis of the intensity of each amide band was performed in the presence and absence of MNP treatment. The data are presented as the ratio of Aβ treated with MNPs (T) to Aβ without MNPs (control, T0), as shown in eq . 5 TT0=IntensityofAβtreatedwithMNPsIntensityofAβtreatedwithoutMNPs(control) The oxidation of Aβ samples in the presence and absence of MNPs was characterized using the CO, C–O, and C–H functional groups by ATR-FTIR spectrometry. , The functional group indices were calculated based on the ratio of the intensity of the functional group to that of the methylene group (the reference/control group). The data are presented as the ratio of each functional group index of Aβ treated with MNPs (T) to Aβ without MNPs (control, T 0), as depicted in eq . 6 TT0=FunctionalgroupindexofAβtreatedwithMNPsFunctionalgroupindexofAβtreatedwithoutMNPs(control) Raman spectra were recorded between 500 cm–1 and 3500 cm–1 using a Renishaw confocal Raman microscope to assess vibrational changes in Aβ after PET MNP exposure, following baseline correction. The analysis focused on Aβ backbone-, Amide III/C–O-, and aromatic-residue-associated regions, especially 1200–1350 cm–1 and Phe/Tyr-related bands. These changes were interpreted as supportive evidence of local structural and interfacial modulation, rather than direct proof of a specific fibrillar morphology. Spectral Leaching Analysis The spectral leaching characterization of MNP-exposed and control samples was tested using the slope factor by UV–vis microplate reader (SF, A275–295/A350–400). , The results are listed as the ratio of SF of Aβ treated with MNPs to Aβ without MNPs (control), as depicted in eq . 7 SFSF0=SFofAβtreatedwithMNPsSFofAβtreatedwithoutMNPs(control) Molecular Docking Simulations The docking studies were performed on two different forms of Aβ; β sheet Aβ42 protofibril oligomer (PDB ID: 5OQV) and a helical monomer (Aβ1–42) (PDB ID: 1IYT). 3D structures were retrieved from the PDB. PyMOL was used to delete water molecules, heteroatoms, and conformers other than the first conformer. Missing hydrogen atoms were added at a pK a value of 7.4 using PDB 2PQR. The Gasteiger charges were added, and the structure was converted to the PDBQT format using ADFR. For PET, a structure consisting of only three monomers (3PET) was selected, consistent with our previous studies. − 3PET was modeled using RDKit, hydrogen atoms were added and Gasteiger charges were applied. The resulting structure was then converted to PDBQT format by adding torsions using Meeko. AutoDock Vina version 1.2.5 was used for docking simulations. Five repeats were conducted for each structure and the average binding affinity values were obtained. The grid box location was determined using the findings of previous studies, which identified two regions that play a significant role in binding: (i) a central hydrophobic region (Leu17–Ala21) and (ii) a secondary hydrophobic region (Gly29–Met35). − Therefore, for 1IYT, the grid box is situated in the proximity of the central hydrophobic region; for 5OQV, it encompasses both hydrophobic regions due to its folded structure. The dimensions of the grid box were set to 18 × 20 × 28 Å for 1IYT and 20 × 24 × 24 Å for 5OQV, with a grid spacing of 1 Å. After the docking process, the interaction maps were subjected to analysis using Discovery Studio and PyMOL. , Statistical Analysis Setups were triplicate, and each analysis result was presented as the mean value of three replicates. The average of each setup is specified as 1 result collected with analysis repetitions, n = 3. The error of each parameter is presented as SD (%). The differences between the control and the samples were analyzed by ANOVA with post hoc Tukey (p < 0.05). Results and Discussion Time-Dependent Fluorescence Response of Aβ after PET MNP Exposure Aβ–PET MNP interactions were evaluated using four complementary Ex/Em pairs, including Tyr-associated intrinsic fluorescence at 215/310 nm, deep-UV peptide/aromatic fluorescence at 220/287 nm, environment-sensitive autofluorescence at 350/435 nm, and longer-wavelength interaction- or oxidation-related emission at 412/490–570 nm. − ,− Results were expressed as fluorescence intensity ratios (F/F 0), where F is the PET MNP-exposed sample and F 0 is the time-matched Aβ control after exposure to 10, 40, and 100 μg/mL PET MNPs for 1–144 h (Figure ), reflecting time-dependent fluorescence modulation rather than a formal kinetic model. Time-dependent fluorescence modulation of Aβ after PET MNP exposure. Fluorescence intensity ratios are shown as F/F 0, where F represents PET MNP-exposed Aβ samples and F 0 represents the corresponding time-matched Aβ control. Panels show Aβ exposed to 10, 40, and 100 μg/mL PET MNPs at four fluorescence conditions: Ex 215 nm/Em 310 nm (A–C), Ex 220 nm/Em 287 nm (D–F), Ex 350 nm/Em 435 nm (G–I), and Ex 412 nm/Em 490–570 nm (J–L). Aβ concentrations were 0.1, 10, 100, and 1000 pg/mL, and exposure durations were 1, 4, 24, 48, and 144 h. Data are presented as mean ± SD, n = 3. At Ex 215 nm/Em 310 nm, PET MNP exposure caused measurable but moderate changes in Tyr-associated fluorescence (Figure A–C). The F/F 0 ratios generally ranged around 0.95–1.12, suggesting that the Tyr10-associated fluorescence environment was altered under selected conditions, although the response was not uniform for all treatments. ,, At 10 μg/mL MNPs, transient increases were observed, including a clear elevation near 4 h for 10 pg/mL Aβ and near 24 h for 0.1 pg/mL Aβ. At 40 μg/mL MNPs, the response was more stable but remained slightly above the control for several Aβ concentrations. At 100 μg/mL MNPs, the 10 pg/mL Aβ group showed a more pronounced increase around 24 h, whereas the 100 pg/mL group remained closer to, or slightly below, the control at some time points. Overall, the Ex 215/310 nm signal showed dose-, time-, and Aβ concentration-dependent fluorescence modulation rather than a completely unchanged response. Since Aβ contains a single Tyr residue at position 10, these changes may indicate local alterations around Tyr10, including changes in solvent accessibility, local peptide environment, or MNP-associated interactions. ,,,, At Ex 220 nm/Em 287 nm, indicating peptide backbone/aromatic transitions and phenylalanine-related fluorescence, the fluorescence response was condition-dependent but moderate (Figure D–F). At 10 μg/mL MNPs, 10 pg/mL Aβ increased to approximately 1.08 ± 0.03 at 4 h and then returned toward control levels. At 40 μg/mL MNPs, most F/F0 ratios remained relatively stable, generally within 0.93–1.05. In contrast, 100 μg/mL MNPs produced a clearer time-dependent shift, with the 10 pg/mL Aβ group increasing to approximately 1.12 ± 0.02 at 24 h and decreasing to approximately 0.88 ± 0.03 at 144 h. The 100 pg/mL Aβ group also remained slightly below control in several cases. These changes may reflect partial masking or redistribution of aromatic/peptide fluorescence within Aβ–MNP-associated microenvironments. Since Aβ contains intrinsic aromatic residues, including Tyr10, this spectral response is interpreted as local fluorescence microenvironment modulation. ,, At Ex 350 nm/Em 435 nm, which may reflect secondary structural rearrangement, chromophore exposure/masking, or aggregate-related optical effects rather than primary peptide backbone fluorescence, ,, fluorescence ratios were mostly close to the control, although concentration-dependent deviations were evident (Figure G–I). Lower and intermediate Aβ concentrations showed only small temporal fluctuations, whereas the 1000 pg/mL Aβ group frequently remained below control, commonly around 0.90–0.99. For example, this group reached approximately 0.91 ± 0.01 at 4 h under 10 μg/mL MNPs and approximately 0.90 ± 0.02 at 24 h under 40 μg/mL MNPs. These decreases may reflect partial fluorophore masking, local self-quenching, peptide crowding, or altered scattering/background effects in denser Aβ–MNP-associated microenvironments. Similar fluorescence-based changes have been associated with altered peptide microenvironments and peptide–particle interactions in Aβ systems. ,, The strongest and most heterogeneous changes were observed at Ex 412 nm/Em 490–570 nm (Figure J–L), where deviations from control were greater than those observed in the intrinsic aromatic fluorescence regions. At 10 μg/mL MNPs, the 10 pg/mL Aβ group decreased markedly at 4 h to approximately 0.71, followed by recovery toward or above control at 24–144 h. At 40 μg/mL MNPs, early enhancement was observed for 10 and 1000 pg/mL Aβ, reaching approximately 1.17–1.22 at 1 h, followed by decreases at 4–48 h and partial recovery at 144 h. At 100 μg/mL MNPs, 0.1 pg/mL Aβ showed an early increase of approximately 1.23 at 1 h, whereas 1000 pg/mL Aβ decreased below control at later exposure times. These patterns indicate that the longer-wavelength fluorescence region was particularly sensitive to Aβ–MNP exposure. The observed changes may reflect heterogeneous chromophore-like fluorescence, oxidation-related fluorescence, particle-associated background or scattering effects, and interaction-induced changes in the peptide–particle microenvironment rather than simple quenching alone. This interpretation is consistent with reports showing that nanoparticle–biomolecule interactions can modify fluorescence responses and that microplastic-related materials may exhibit or influence fluorescence signals depending on particle surface chemistry, oxidation state, and matrix interactions. ,− Statistical analysis further confirmed the nonuniform nature of the long-wavelength fluorescence response. Two-way ANOVA showed significant effects of MNP dose, exposure duration, and their interaction (p < 0.05). Tukey’s HSD analysis identified significant differences from time-matched controls under multiple conditions. At 10 μg/mL MNPs, all Aβ concentrations differed significantly from controls except 100 pg/mL Aβ at 144 h. At 40 μg/mL MNPs, significant differences were observed for 0.1 pg/mL Aβ at 4, 48, and 144 h; for 10 and 100 pg/mL Aβ at 1, 4, 24, and 144 h; and for 1000 pg/mL Aβ at 1, 24, 48, and 144 h. At 100 μg/mL MNPs, significant differences were detected for 0.1 pg/mL Aβ at 1, 4, and 24 h; for 10 and 1000 pg/mL Aβ at all exposure durations; and for 100 pg/mL Aβ at 1 h only. Overall, these results show that PET MNPs significantly modified the long-wavelength fluorescence response under selected dose-, time-, and Aβ concentration-dependent conditions. The apparent Stern–Volmer-type evaluation was consistent with the nonclassical and condition-dependent fluorescence behavior observed in the intensity data (Table S2). In the combined fitted KSV,app table, individual slopes were small and bidirectional, ranging approximately from −3.0 × 10–3 to +1.7 × 10–3 mL/μg, with both positive and negative values observed across spectral conditions, Aβ concentrations, and exposure durations. Several fits also showed modest or low R 2 values, indicating that the fluorescence response was not consistently linear or monotonic with MNP dose. Positive Ksv,app values describe apparent fluorescence suppression with increasing MNP concentration, whereas negative values describe fluorescence enhancement relative to the time-matched control or other nonclassical behavior. ,− Such bidirectional responses are compatible with multiple simultaneous contributions, including peptide–particle association, local microenvironmental changes, scattering/background effects, fluorophore masking, or fluorescence enhancement. ,− Therefore, Ksv,app is used here only as an empirical descriptor of MNP-dose-dependent fluorescence modulation. It should not be interpreted as evidence of a single dynamic quenching mechanism, binding constant, binding-site number, bimolecular quenching rate, or fibril formation. Overall, Figure demonstrates that MNP exposure produced wavelength-specific, time-dependent, and concentration-dependent fluorescence modulation in Aβ solutions. The intrinsic fluorescence regions, especially Ex 215/310 nm and Ex 220/287 nm, showed moderate but detectable changes, while the longer-wavelength region exhibited the most pronounced variability. Together with the apparent Stern–Volmer analysis, these results support an interaction between Aβ and PET MNPs involving changes in aromatic residue microenvironment, possible surface association, and heterogeneous chromophore-related responses. However, the mixed direction of the Ksv,app slopes indicates that the fluorescence results should not be described as uniform quenching or used alone to infer a single binding mechanism. Thus, the fluorescence data indicate PET MNP-induced modulation of the Aβ microenvironment, particularly around aromatic-residue- and long-wavelength emission regions. However, these optical responses should be regarded as interaction-related fluorescence evidence and should not be used alone to infer fibril formation, fibril inhibition, or a defined aggregate morphology. Biophysical Characterization of Aβ–MNP Agglomeration Dynamics To evaluate the colloidal stability and exposure-duration-dependent agglomeration behavior of Aβ after PET MNP exposure, turbidity, RLS, zeta potential, and particle size distribution measurements were evaluated together. These parameters provide complementary information on the optical and physicochemical status of the system. Turbidity reflects changes in larger light-scattering assemblies and phase heterogeneity, RLS is sensitive to nanoscale and submicron scattering structures, zeta potential indicates surface charge and electrostatic stability, and DLS-derived particle size distribution provides the apparent hydrodynamic size of dispersed species. Therefore, their combined assessment provides a broader biophysical view of Aβ–MNP interactions than any single measurement alone. Turbidity measurements were used as an optical indicator of Aβ-associated assembly formation and aggregation-related scattering. Turbidity is widely applied to monitor protein aggregation, protein–polymer complexation, coacervation, and changes in protein folding or refolding states; however, it reports light scattering rather than specific aggregate morphology. ,,− In the present study, PET MNP exposure caused a clear but nonmonotonic modulation of Aβ turbidity (Figures A–C and S2A–C). During the early exposure stage, particularly at 1–4 h, turbidity increased under several experimental conditions, with T/T0 values reaching up to approximately 1.36. This early increase suggests enhanced formation of light-scattering Aβ–MNP-associated assemblies or colloidal heteroassociations, consistent with the known sensitivity of turbidity to protein aggregation, coacervate formation, and particle/protein clustering. ,,, However, turbidity did not continuously increase with exposure duration. At longer exposure times, particularly from 24 to 144 h, turbidity values decreased under many conditions, in some cases to approximately 0.85. This decrease indicates a reduction in the abundance or scattering efficiency of larger light-scattering species remaining in the measured phase. However, because direct morphological imaging by SEM, TEM, or AFM was not performed, the underlying mechanism cannot be assigned specifically to structural compaction or surface reorganization. Alternative and equally plausible explanations include microsedimentation, localized precipitation, nonspecific adsorption of Aβ to the incubation vessel walls, filtration-sensitive loss, redistribution between suspended and removed fractions, or changes in optical scattering efficiency. ,,− Therefore, the turbidity results are interpreted as evidence of a time-dependent change in the colloidal state of the Aβ–PET MNP system rather than direct evidence of a defined aggregate morphology, fibril formation, fibril inhibition, or a specific reorganization mechanism. Turbidity and Rayleigh light scattering responses of Aβ after PET MNP exposure. Turbidity ratios (T/T 0) were presented as the ratio of the turbidity of Aβ treated with MNPs (T) to the turbidity of Aβ treated without MNPs (control, T 0), and Rayleigh light scattering ratios (RLS/RLS0) were presented as the ratio of the RLS of Aβ treated with MNPs (RLS) to the RLS of Aβ treated without MNPs (control, RLS0) used as complementary optical indicators of light-scattering Aβ-associated assemblies after exposure to 10, 40, and 100 μg/mL PET MNPs. Panels A–C show turbidity responses, and panels D–F show RLS responses at 350/350 nm. Aβ concentrations were 0.1, 10, 100, and 1000 pg/mL, and exposure durations were 1, 4, 24, 48, and 144 h. Data are presented as mean ± SD, n = 3. RLS measurements further supported the turbidity-based interpretation (Figures D–F and S2D–F). RLS was measured at 350/350 nm, a spectral condition where elastic light scattering rather than intrinsic Aβ fluorescence is expected to dominate. RLS and related scattering-based measurements are commonly used to follow protein aggregation, colloidal assembly formation, opalescence, and particle-mediated clustering, but they cannot independently define the morphology or molecular structure of the assemblies. ,,, Similar to turbidity, RLS increased during early PET MNP exposure in several treatments, with RLS/RLS0 values reaching up to approximately 1.21. This early elevation is consistent with rapid particle–peptide association and formation of scattering Aβ–MNP-associated assemblies. However, prolonged exposure was generally associated with reduced RLS intensity, with values decreasing to approximately 0.81 under some conditions. The parallel decline in turbidity and RLS at longer incubation times indicates a reduction in the abundance or scattering efficiency of larger light-scattering species remaining in the measured filtrate. However, these optical changes do not by themselves demonstrate disaggregation, fibril degradation, structural compaction, or surface reorganization. In the absence of direct morphological imaging by SEM, TEM, or AFM, several alternative explanations remain plausible, including microsedimentation, localized precipitation, nonspecific adsorption of Aβ to the incubation vessel walls, filtration-sensitive loss, redistribution between suspended and removed fractions, and changes in optical scattering efficiency. ,− Because turbidity and RLS are indirect optical indicators, the findings are therefore interpreted as evidence of a time-dependent change in the measured colloidal state of the Aβ–PET MNP system rather than as direct confirmation of mature fibrils, fibril inhibition, fibril breakdown, or any specific structural reorganization mechanism. Zeta potential measurements provided additional evidence that MNPs modified the electrostatic stability of Aβ dispersions (Table ). Control Aβ samples exhibited consistently negative zeta potentials, generally ranging from approximately −34.0 to −23.7 mV at early exposure and remaining negative throughout the incubation period. Upon MNP exposure, zeta potentials shifted in a concentration-, dose-, and time-dependent manner. For example, at 0.1 pg/mL Aβ, the control value at 1 h was −34.0 ± 0.1 mV, whereas exposure to 100 μg/mL MNPs shifted the value to −25.7 ± 0.1 mV. At 10 pg/mL Aβ, the 100 μg/mL MNP treatment also shifted the zeta potential to less negative values at early exposure, reaching −19.7 ± 0.9 mV at 1 h and −18.4 ± 1.1 mV at 4 h. These changes indicate partial charge neutralization and reduced electrostatic repulsion, which can facilitate Aβ–MNP association. However, the zeta potential response was not uniform for all concentrations or time points. For instance, at 100 pg/mL Aβ, some MNP-treated samples became more negative than the corresponding controls at later exposure stages. This nonmonotonic behavior suggests dynamic interfacial rearrangement rather than simple charge screening alone. Similar shifts toward reduced surface charge magnitude have been reported for Aβ–PET MNP complexes, where decreased electrostatic stability was associated with enhanced aggregation propensity. ,− 1Zeta Potential of Aβ When Exposed to MNP and Non-Exposed MNP exposure and doseexposure durationAβ concentration 1 h4 h24 h48 h144 h0.1 pg/mL AβControl–34.0 ± 0.1–33.9 ± 0.1–29.8 ± 0.1–28.1 ± 0.1–27.4 ± 0.2 10 μg/mL MNP–36.3 ± 0.3–34.1 ± 0.2–26.5 ± 0.1–23.4 ± 0.1–26.1 ± 0.1 40 μg/mL MNP–35.9 ± 0.2–34.8 ± 0.4–24.7 ± 0.2–26.4 ± 0.3–28.3 ± 0.2 100 μg/mL MNP–25.7 ± 0.1–24.2 ± 0.1–24.6 ± 0.3–22.1 ± 0.5–23.2 ± 0.410 pg/mL Aβcontrol–27.4 ± 0.7–27.6 ± 0.3–28.3 ± 0.8–28.1 ± 0.3–27.0 ± 0.6 10 μg/mL MNP–29.1 ± 0.2–29.4 ± 0.8–25.6 ± 0.5–25.6 ± 0.5–26.6 ± 0.9 40 μg/mL MNP–27.2 ± 0.8–28.9 ± 0.6–22.2 ± 0.9–18.9 ± 1.2–23.9 ± 0.7 100 μg/mL MNP–19.7 ± 0.9–18.4 ± 1.1–26.9 ± 0.6–27.8 ± 0.5–27.3 ± 0.9100 pg/mL AβControl–27.8 ± 1.3–27.7 ± 0.9–27.4 ± 1.0–26.1 ± 0.8–26.3 ± 1.2 10 μg/mL MNP–28.3 ± 0.7–27.4 ± 1.0–31.2 ± 1.9–28.8 ± 1.7–29.6 ± 0.9 40 μg/mL MNP–26.6 ± 0.7–28.6 ± 1.0–29.8 ± 2.1–20.4 ± 0.8–29.8 ± 0.9 100 μg/mL MNP–28.8 ± 0.6–29.4 ± 0.9–30.7 ± 1.6–30.2 ± 2.5–30.9 ± 3.11000 pg/mL Aβcontrol–26.9 ± 0.3–27.4 ± 0.5–26.1 ± 0.3–23.9 ± 0.9–24.1 ± 0.7 10 μg/mL MNP–19.8 ± 1.3–15.9 ± 1.7–20.3 ± 0.9–27.2 ± 1.4–25.9 ± 1.9 40 μg/mL MNP–17.7 ± 2.7–19.4 ± 1.3–25.9 ± 1.7–24.2 ± 2.9–27.9 ± 2.1 100 μg/mL MNP–27.0 ± 2.9–21.6 ± 0.8–26.5 ± 0.9–23.8 ± 1.5–20.9 ± 1.8aThe results are presented as mean ± SD (n = 3). Zeta Potential of Aβ When Exposed to MNP and Non-Exposed The results are presented as mean ± SD (n = 3). DLS-based particle size distribution was used to evaluate the apparent hydrodynamic size of species present after filtration (Figures S3 and S4). The untreated Aβ controls showed small nanoscale dimensions, ranging from approximately 0.62 to 5.61 nm. After PET MNP exposure, larger apparent hydrodynamic sizes were detected under selected conditions, with the maximum recorded size reaching approximately 50.75 nm at 1000 pg/mL Aβ exposed to 100 μg/mL PET MNPs after 144 h. These results suggest the presence of nanoscale Aβ-associated species or Aβ–MNP-related assemblies after exposure. However, the DLS results should be interpreted cautiously because DLS reports an intensity-weighted hydrodynamic diameter and can be strongly influenced by polydispersity, weak agglomeration, changes in scattering efficiency, and small populations of larger scatterers. ,, Therefore, the size data support nanoscale association or colloidal reorganization but should not be used alone as evidence of mature fibril formation or defined aggregate morphology. The DLS results also help address potential concerns about residual PET particles in the optical measurements. The original PET MNPs were approximately 270–500 nm, whereas the postfiltration DLS signals mainly appeared within the nanoscale protein-associated range and did not show dominant populations corresponding to the original PET MNP size range. Table S1 further indicates that the filtration/recovery procedure removed most added PET MNPs, with recovery values of approximately 83.0–97.3%. Thus, the optical responses are more likely to reflect Aβ-associated species, nanoscale interaction products, or exposure-induced restructuring rather than persistent scattering from intact PET particles. Nevertheless, smaller PET-derived fragments, dissolved components, or filtration-sensitive colloidal species cannot be fully excluded. Therefore, these findings should be interpreted as Aβ–PET MNP interaction-driven biophysical changes rather than particle-free Aβ aggregation alone. Overall, the combined turbidity, RLS, zeta potential, and DLS results support a time-dependent colloidal response involving early Aβ–PET association followed by nanoscale redistribution or restructuring. Since no direct microscopic imaging was included, the observed changes are interpreted as biophysical indicators of colloidal reorganization rather than morphological proof of mature fibrils or insoluble aggregate structures. FTIR and Raman Evidence for Aβ Structural Reorganization and PET Surface Interactions To evaluate structural changes in Aβ after PET MNP exposure, FTIR and Raman spectroscopic analyses were combined with semiquantitative band-index evaluation. The amide regions of Aβ were examined by FTIR spectroscopy, focusing on Amide I, II, and III bands, which are commonly used to monitor peptide/protein backbone conformation, hydrogen-bonding environment, and secondary-structure-related vibrational changes (Figures S5, S6, S7, S8, and ). − The corresponding band intensities were expressed as ratios of MNP-exposed Aβ to time-matched Aβ controls, allowing the structural effect of MNP exposure to be evaluated relative to baseline incubation effects. The Amide I region showed only modest variation after PET MNP exposure compared with the Amide II and Amide III regions. Although some statistically significant differences were observed, the overall Amide I response remained close to the control level for most Aβ concentrations, MNP doses, and exposure durations (Figure A–C). This suggests that MNP exposure did not cause a uniform or extensive change in the dominant carbonyl-stretching environment of the peptide backbone. Instead, the limited Amide I modulation indicates a subtle structural response, rather than a simple monotonic shift toward a defined fibrillar state. This interpretation is consistent with the DLS and scattering results, which indicated nanoscale redistribution and colloidal reorganization rather than continuous growth into large insoluble structures. In contrast, Amide II and Amide III bands exhibited more pronounced and time-dependent changes after MNP exposure (Figure D–I). The Amide II index generally increased with prolonged exposure, especially at later time points, indicating changes in N–H bending and C–N stretching environments (Figure D–F). Similarly, the Amide III index showed a stronger response than Amide I, with the most evident increases occurring at prolonged exposure stages (Figure G–I). These changes suggest that MNPs promoted rearrangement of hydrogen-bonding networks and backbone-associated vibrational modes rather than causing a single-directional increase in fibril-like β-sheet content. Previous studies have shown that oxidative modification and molecular interactions can alter protein amide bands by changing conformation, stability, solvent accessibility, and aggregation susceptibility. − Therefore, the stronger response of Amide II/III compared with Amide I supports changes in the local backbone and hydrogen-bonding environments of Aβ after MNP exposure. − Importantly, these spectral changes should not be interpreted as direct evidence of mature fibril formation or physical compaction. Rather, they indicate local vibrational changes consistent with interfacial association or redistribution of Aβ-containing species. FTIR-based amide band indices of Aβ after PET MNP exposure. Semiquantitative FTIR band indices are shown as ratios of PET MNP-exposed Aβ samples to time-matched Aβ controls. Panels show changes in Amide I (A–C), Amide II (D–F), and Amide III (G–I) regions after exposure to 10, 40, and 100 μg/mL PET MNPs for 1, 4, 24, 48, and 144 h. Aβ concentrations were 0.1, 10, 100, and 1000 pg/mL. Data are presented as mean ± SD, n = 3. Raman spectroscopy was incorporated as an additional structure-sensitive technique to support the FTIR-based interpretation (Figure S9). The Raman spectra showed time-, dose-, and concentration-dependent changes in broad spectral regions associated with Aβ backbone vibrations, aromatic residues, and C–C/C–N/C–O-related vibrational modes. Although the Raman response was not monotonic for all experimental conditions, changes around 1200–1350 cm–1 were consistent with modulation of Amide III/C–O-related vibrations, supporting the FTIR evidence of backbone and hydrogen-bonding rearrangement. Changes in aromatic-residue-associated regions, including bands related to Phe and Tyr environments, suggest that MNP exposure altered the local microenvironment of Aβ aromatic residues. This is mechanistically plausible because Aβ contains aromatic residues that may participate in hydrophobic or π-related interactions with the aromatic terephthalate structure of PET. The Raman results therefore complement the fluorescence data, where changes in Tyr/Phe-associated emission and mixed apparent Stern–Volmer slopes suggested heterogeneous Aβ–PET interfacial modulation rather than simple dynamic quenching. In addition to Aβ structural analysis, FTIR spectroscopy of MNPs after Aβ exposure was used to evaluate whether peptide–particle interactions produced detectable changes on the plastic surface (Figure S10). Control PET MNPs showed characteristic PET absorption bands, including the ester carbonyl stretching band around 1715 cm–1, C–O stretching vibrations near 1240 cm–1, C–O–C/O–CH2 vibrations around 1090–1110 cm–1, and fingerprint-region bands near 872 and 725 cm–1 associated with terephthalate ring deformation and CH2 wagging. After incubation with Aβ, several PET-associated bands showed attenuation or slight spectral modification, particularly in the ester and fingerprint regions. These changes suggest surface-level perturbation of PET MNPs, most likely due to peptide adsorption, surface masking, or interfacial interactions involving PET ester groups and Aβ functional groups. Modest changes in O–H/N–H and amide-related regions may also reflect the presence of Aβ-associated material on the PET surface after incubation. Therefore, the PET FTIR results provide complementary evidence that the interaction involved not only changes in the filtered Aβ phase, but also modification of the apparent PET surface spectral environment. Nevertheless, these PET FTIR changes should be interpreted cautiously. The attenuation of PET bands supports adsorption-driven surface masking and interfacial association, but it does not by itself demonstrate extensive PET chemical degradation. Taken together, the FTIR and Raman results support PET MNP-associated changes in Aβ vibrational environments, including backbone-, hydrogen-bonding-, and aromatic-residue-related regions. These spectroscopic signatures are consistent with structural reorganization at the peptide–particle interface, but they do not provide direct morphological confirmation of fibrillar assembly, fibril inhibition, or fibril disruption. Oxidative Potential and Spectral Leaching Characteristics of Aβ–MNP Systems The OP of Aβ–MNP systems was evaluated using the cell-free DTT assay, which reflects the capacity of redox-active species or chemically reactive components to consume DTT under controlled conditions (Figures and S11). PET MNP exposure produced a modest but measurable increase in OP in many experimental groups. Across the tested Aβ concentrations, MNP doses, and exposure durations, DTT consumption generally increased by approximately 3–15% relative to time-matched Aβ controls. These results suggest that MNP exposure altered the redox-active chemical environment of the Aβ-containing medium. OP of Aβ–PET MNP systems assessed by the DTT assay. OP was evaluated as the ratio of DTT consumption in PET MNP-exposed Aβ samples to that in time-matched Aβ controls. Aβ samples were exposed to 10 (A), 40 (B), and 100 μg/mL (C) PET MNPs for 1, 4, 24, 48, and 144 h. Aβ concentrations were 0.1, 10, 100, and 1000 pg/mL. Data are presented as mean ± SD, n = 3. The OP response depended on Aβ concentration and exposure duration. At lower and intermediate Aβ concentrations, OP responses were variable but frequently elevated after MNP exposure. At the highest Aβ concentration, OP increases were observed under several conditions, suggesting that peptide loading may influence the apparent redox response, possibly through changes in the availability of oxidizable functional groups, peptide–particle association, or interactions with PET-derived dissolved components. ,, Statistical analysis indicated significant differences from time-matched controls in most experimental conditions (p < 0.05). Nonsignificant responses were limited to selected conditions, including low MNP exposure at 0.1 pg/mL Aβ after 1 and 48 h, 10 pg/mL Aβ after 144 h, 100 pg/mL Aβ after 144 h, and 1000 pg/mL Aβ after 144 h. Under medium MNP exposure, nonsignificant differences were observed at 10 pg/mL Aβ after 144 h and 100 pg/mL Aβ after 1 h. Under the highest MNP dose, nonsignificant responses were observed at 10 pg/mL Aβ after 24 h and 1000 pg/mL Aβ after 144 h. This distribution indicates that the OP response was not uniform for the exposure matrix. The increase in DTT consumption may reflect several interacting processes, including PET-derived dissolved constituents, formation of surface-associated reactive species, or oxidative modification of Aβ functional groups. Previous studies have shown that MNPs can release dissolved organic matter and modify oxidative behavior in biological or protein-containing media. − However, because the DTT assay is cell-free, these results should be interpreted as OP rather than direct cellular oxidative stress. As illustrated in Figures and S12, FTIR-derived functional group indices of Aβ provided additional evidence of chemical and interfacial modulation. The CO index, used here as a semiquantitative indicator of carbonyl-associated vibrational contributions and possible oxidation-related changes in carbonyl-containing groups, remained close to control for most conditions, generally ranging within approximately 0.96–1.01, indicating limited carbonyl-associated modulation. The strongest CO decreases were observed at early to intermediate time points in some conditions, whereas values often returned toward control levels at prolonged exposure. This suggests that oxidation-related carbonyl modulation was detectable but was not the dominant spectral response. ,− , The C–H index showed greater variability than CO. Depending on dose and exposure duration, C–H ratios ranged approximately from 0.65 to 1.06 (Figure D–F). The most pronounced decrease was observed under low MNP exposure at the lowest Aβ concentration after prolonged exposure, where the C–H index decreased to approximately 0.65. Other conditions showed moderate increases or decreases around the control level. These C–H changes may reflect altered hydrophobic environments, peptide–PET surface association, or contributions from PET-associated aliphatic/aromatic structures. ,,− Because both PET-derived components and peptide conformational changes can influence this region, the C–H index should be interpreted as an indicator of interfacial chemical reorganization rather than a marker of a single oxidation product. FTIR-derived functional group indices of Aβ after PET MNP exposure. Functional group indices were calculated from FTIR spectra and expressed as ratios of PET MNP-exposed Aβ samples to time-matched Aβ controls. Panels show CO (A–C), C–H (D–F), and C–O-associated index (G–I) changes after exposure to 10, 40, and 100 μg/mL PET MNPs for 1, 4, 24, 48, and 144 h. Aβ concentrations were 0.1, 10, 100, and 1000 pg/mL. Data are presented as mean ± SD, n = 3. The C–O index, used here as a semiquantitative indicator of C–O-associated vibrational contributions, oxygen-containing functional group rearrangement, and possible oxidation- or interface-related chemical modulation, showed the clearest prolonged-exposure pattern (Figure G–I). At the lowest Aβ concentration, C–O ratios increased at 144 h, reaching approximately 1.14 under 10 μg/mL MNP exposure, 1.06 under 40 μg/mL MNP exposure, and 1.03–1.04 under 100 μg/mL MNP exposure. In the time-dependent plots, C–O values were generally close to control during early exposure but increased at 144 h, especially at lower Aβ concentrations. This trend suggests increased C–O-associated vibrational contributions after prolonged MNP exposure, consistent with interfacial modification, oxygen-containing functional group rearrangement, mild oxidation-related modulation, or contributions from PET-derived dissolved/associated components. ,− , The prolonged C–O response is also consistent with the Amide II/III and Raman changes, suggesting that chemical and backbone-associated spectral changes occurred together, although this does not prove a specific structural morphology. − Together, the DTT and FTIR index results indicate that PET MNP exposure produced both redox-active and structural-chemical changes in the Aβ system. The moderate OP increase, accompanied by C–O and C–H modulation, suggests the development of a reactive interfacial environment that may contribute to functional group rearrangement, altered solvent accessibility, or more surface-associated Aβ conformations. This interpretation is consistent with the prolonged decrease in turbidity and RLS, which indicates a reduction in the abundance or scattering efficiency of larger light-scattering species remaining in the measured phase. However, in the absence of direct morphological imaging, the underlying cause cannot be assigned specifically to redistribution or compaction. Microsedimentation, localized precipitation, and changes in optical scattering efficiency remain plausible explanations for the reduced turbidity and RLS signals. ,, Moreover, nonspecific adsorption of Aβ to vessel surfaces and adsorption or retention during membrane filtration cannot be excluded. − Spectral leaching behavior was further evaluated using the UV–Vis SF (Table ). SF was used as an optical indicator of chromophoric redistribution and low-molecular-weight dissolved components in the Aβ–MNP systems. Spectral slope indices are commonly used to infer changes in chromophoric dissolved organic matter composition, molecular weight, source, and transformation state, although they should be interpreted as indirect optical indicators rather than compound-specific measurements. − Although the magnitude of SF changes was modest, the response depended on Aβ concentration, MNP dose, and exposure duration. At low and intermediate Aβ concentrations, MNP exposure produced transient SF increases, especially between 4 and 48 h. Under these conditions, SF ratios increased to approximately 1.02–1.33, suggesting early chromophoric enrichment, redistribution, or contribution from optically active dissolved/associated components. , The highest SF responses occurred at low Aβ concentration, where the system may be more sensitive to PET-derived dissolved species and Aβ surface-associated optical changes. At 1000 pg/mL Aβ, SF ratios were generally close to or slightly below the control, typically ranging from approximately 0.92 to 1.00. This may indicate optical buffering, reduced apparent sensitivity to PET-associated chromophores, or altered retention/association of chromophoric components under higher peptide loading. This behavior is broadly consistent with the fluorescence and FTIR/Raman results, which indicated wavelength-dependent fluorescence modulation and surface-associated structural reorganization, but it should not be interpreted as direct evidence of a defined aggregate or fibrillar state. 2Slope Factor (SF) Ratio of Aβ with and without MNP Exposures Obtained from UV-VIS Spectrometry Aβ concentrationexposure durationMNP exposure dose 1 h4 h24 h48 h144 h10 μg/mL MNP treatment of Aβ0.1 pg/mL of Aβ1.001.191.060.960.92 10 pg/mL of Aβ1.081.131.071.031.00 100 pg/mL of Aβ1.051.141.121.011.04 1000 pg/mL of Aβ0.940.990.970.950.9340 μg/mL MNP treatment of Aβ0.1 pg/mL of Aβ1.021.251.070.961.01 10 pg/mL of Aβ0.981.081.021.010.99 100 pg/mL of Aβ0.981.040.991.030.99 1000 pg/mL of Aβ0.920.970.940.980.95100 μg/mL MNP treatment of Aβ0.1 pg/mL of Aβ1.011.171.061.000.94 10 pg/mL of Aβ0.971.070.951.040.99 100 pg/mL of Aβ0.971.011.001.060.96 1000 pg/mL of Aβ0.931.000.930.970.95aThe SF ratio is calculated as the SF of Aβ treated with MNPs to Aβ without MNPs (control) at all Aβ concentrations, exposure times, and MNP doses (n = 3, SD < 2.7%). Slope Factor (SF) Ratio of Aβ with and without MNP Exposures Obtained from UV-VIS Spectrometry The SF ratio is calculated as the SF of Aβ treated with MNPs to Aβ without MNPs (control) at all Aβ concentrations, exposure times, and MNP doses (n = 3, SD < 2.7%). The SF response provides information distinct from the DTT assay reflecting OP. SF primarily reflects spectral/chromophoric redistribution, whereas DTT reflects redox-active chemical potential. ,, Therefore, the observation that SF values returned toward control at prolonged exposure while OP remained elevated in some conditions suggests that chromophoric redistribution and OP do not necessarily follow identical time-dependent patterns. Early SF increases may reflect rapid release, redistribution, or interaction of optically active components during Aβ–PET association. Later normalization of SF may reflect re-equilibration, adsorption to PET surfaces, retention during filtration, or redistribution of Aβ-associated chromophoric species. Accordingly, the oxidative and spectral data are interpreted as evidence of chemical and interfacial reorganization, rather than as direct evidence of a defined fibrillar or aggregate morphology. Molecular Docking Analysis To elucidate the binding mechanism and analyze the interactions between the MNPs and the amyloid structures, 3PET was docked to both 1IYT and 5OQV structures (Figure A–G). As shown in Figure G, the obtained binding energy values are comparable, while 5OQV exhibits stronger binding with lower binding affinity values due to its folded structure, enabling an enhanced interaction profile. Molecular docking of 3PET into the binding region of 1IYT revealed (Figure A–C) both hydrophobic and hydrogen-bonding interactions with key hydrophobic region residues that have previously been implicated in Aβ aggregation, including Phe19, Phe20, Glu22 and Asp23, while the latter two are critical salt bridge forming residues, which are known to stabilize the β-sheet conformation in Aβ1–42. , Furthermore, the aromatic rings of 3PET were involved in π–π stacking interactions with the aromatic side chains of Phe19 and to a lesser extent, Phe20. 3PET may also stabilize nonfibrillar conformers of 1IYT by hydrogen bonding to Glu22 and Asp23, hence preventing salt bridge formation of these residues with Lys28. (A) 5 individual docking conformations of 3PET bound to 1IYT (B) Closer view of a representative 3PET conformation docked to 1IYT (C) 2D interaction map of a representative 3PET bound to 1IYT obtained from Discovery Studio (D) 5 individual docking conformations of 3PET bound to 5OQV (E) Closer view of representative 3PET conformation docked to 5OQV (F) 2D interaction map of a representative 3PET bound to 5OQV obtained from Discovery Studio (G) Binding affinity values obtained as a result of docking simulations are given for both 1IYT and 5OQV. Similarly, molecular docking of 3PET into the binding region of 5OQV revealed extensive hydrogen-bonding networks and hydrophobic contacts (Figure D–F) with the same set of residues. Additionally, in this case, secondary hydrophobic region residues are also found to bind to 3PET due to the folded conformation of this structure. Specifically, Glu22 and Asp23 formed predicted hydrogen-bonding contacts with carbonyl and/or hydroxyl functionalities of 3PET. These contacts may influence residues involved in Aβ intermolecular stabilization. The observed interaction of 3PET with the aromatic clusters of Phe19 and Phe20 could potentially compete with the critical intersheet and intrasheet π–π interactions that are required for the process of fibril elongation. Furthermore, the results obtained from this analysis suggest the presence of hydrogen bonds or polar interactions with secondary hydrophobic region residues, including Asn27, Lys28, Gly29, and Ala30, thus highlighting the ability of 3PET to engage with multiple contact points along the β-strand. This multivalent binding mode may alter in a reduction of the intermolecular forces that are necessary for the process of fibril aggregation. The overall effect of these hydrophobic, hydrogen-bonding, and electrostatic interactions may be to provide a hypothesis for altered peptide–peptide contacts, thereby reducing the propensity for further fibril formation or any other aggregation. The use of 3PET as a representative model to simulate the interfacial interactions between Aβ and PET MNPs is grounded in biophysical and computational considerations. Molecular docking algorithms, including AutoDock Vina, exhibit a documented decrease in conformational search accuracy for ligands exceeding approximately 10–20 rotatable bonds due to the exponential growth of the conformational space. The 3PET model remains well within the optimal range for reliable scoring while sufficiently capturing the physicochemical properties of the polymer surface. Additionally, our previous comparative study on pancreatic enzymes demonstrated that extending the PET fragment length from dimer (2PET) to tetramer (4PET) enhanced binding affinity values while preserving the dominant binding modes and interaction motifs (e.g., π–π stacking and hydrogen bonding). , This suggests that the local chemical interplay observed with 3PET is translatable to longer polymer chains. The docking results provide a molecular rationale for possible Aβ–PET interfacial contacts but should be interpreted together with the nonclassical fluorescence behavior. Docking of 3PET to both 1IYT and 5OQV revealed multivalent interactions with aggregation-prone residues (Phe19, Phe20, Glu22, Asp23, and Lys28), which are relevant to β-sheet stabilization, salt-bridge formation (Asp23–Lys28), and fibril elongation. These predicted contacts may help explain the experimental decline in turbidity and RLS intensities observed at prolonged exposure times by suggesting redistribution, surface binding, or reduced persistence of large light-scattering assemblies. However, because the apparent Ksv slopes were mixed in sign and magnitude and because microscopy was not performed, these data should not be presented as direct evidence of a net antifibrillatory effect or complete prevention of fibril maturation. Rather, the DLS data (Figures S3 and S4) indicate that the measured postfiltration species remained within a nanoscale size range under the tested conditions, supporting nanoscale association/reorganization rather than direct confirmation of micron-scale fibril suppression. Moreover, the docking-predicted hydrogen bonding between 3PET and polar residues (Glu22, Asp23, Asn27, Lys28) aligns with FTIR-derived structural changes, particularly the pronounced alterations in the Amide II and III regions. These FTIR shifts reflect hydrogen-bond rearrangements and reduced solvent accessibility, consistent with possible stabilization of surface-associated or compact Aβ conformations. The elevated OP measured by the DTT assay may further contribute to these structural perturbations by promoting oxidation-related conformational rearrangement, as reflected by C–H and C–O band modulation. Together, oxidative potential and multivalent PET–Aβ contacts provide a plausible mechanism for altered Aβ assembly behavior, without requiring a definitive claim of fibril inhibition. Finally, the fluorescence results are better described as nonmonotonic fluorescence modulation than as conventional quenching. The apparent Stern–Volmer slopes included positive, near-zero, and negative values depending on wavelength, Aβ concentration, and exposure duration, indicating that both fluorescence suppression and enhancement occurred within the exposure matrix. Therefore, the fluorescence response is most consistent with heterogeneous Aβ–PET microenvironments, chromophore masking/exposure, oxidation-related fluorophores, and possible surface-associated complexation, rather than a single ground–state complex formation mechanism. Collectively, the docking, optical scattering, oxidative, and spectroscopic data support a unified but cautious mechanism in which PET-derived MNPs initially promote Aβ association and later coincide with conformational, oxidative, and colloidal reorganization. The Raman spectra also support the docking-based interpretation that PET fragments may interact with aggregation-prone Aβ residues, including Phe19 and Phe20, through hydrophobic or π-related contacts. However, because Raman spectra are sensitive to concentration, baseline, scattering, and local microenvironmental effects, the Raman data are best interpreted as supportive evidence of structural and interfacial modulation, not as direct proof of a specific fibrillar state. Proposed Biphasic Response Framework and Alternative Explanations Overall, the integrated fluorescence, apparent Stern–Volmer, turbidity, RLS, DLS, zeta potential, FTIR, Raman, SF, OP, and docking results support a biphasic Aβ–PET MNP interaction framework. During the early exposure stage, mainly 1–4 h, PET MNPs appear to promote Aβ surface association and formation of light-scattering Aβ–MNP assemblies by partially altering electrostatic stability and providing hydrophobic/aromatic interfacial sites. This stage is reflected by increased turbidity and RLS responses, zeta-potential shifts toward lower charge magnitude under selected conditions, and wavelength-dependent fluorescence modulation. However, the mixed positive, near-zero, and negative apparent Ksv values show that this fluorescence response cannot be reduced to a single conventional quenching process. With prolonged exposure, mainly from 24 to 144 h, the system did not show continuous accumulation of larger light-scattering structures. Instead, the combined optical and spectroscopic changes indicate a time-dependent shift in the abundance, distribution, and measured properties of species remaining in the analyzed phase. These data do not distinguish interfacial reorganization from microsedimentation, localized precipitation, nonspecific vessel-wall adsorption, filtration-sensitive loss, redistribution between suspended and removed fractions, or altered optical scattering efficiency. Molecular docking is consistent with the possibility of PET–Aβ interfacial contacts involving Phe19, Phe20, Glu22, Asp23, and Lys28, but it does not establish the morphology or fate of the associated species. Therefore, PET MNPs are interpreted as time-dependent modulators of Aβ-associated colloidal, spectroscopic, and oxidative behavior rather than as confirmed drivers of structural compaction or formation of smaller, compact assemblies. Because SEM, TEM, or AFM imaging was not performed, these findings should be considered indirect biophysical and spectroscopic evidence of Aβ–PET MNP interaction, not direct morphological confirmation of any defined aggregate structure. The combined results support a proposed time-dependent response framework rather than a morphologically confirmed compaction mechanism. The early increases in turbidity and RLS are compatible with the formation of light-scattering Aβ–PET-associated species. The subsequent decrease in optical scattering indicates a change in the abundance, distribution, or scattering efficiency of species remaining in the measured phase. However, the present experiments cannot distinguish structural or interfacial reorganization from microsedimentation, localized precipitation, nonspecific adsorption to the incubation vessel, or loss during filtration. Limitations, Strengths, and Future Directions This study has several limitations that should be considered when interpreting the findings. First, it should be noted that the PET MNP concentrations used in this study were selected to provide a controlled in vitro dose–response window and should not be interpreted as direct environmental or brain-tissue exposure levels. Although the tested range is consistent with concentrations used in previous neurotoxicity-related in vitro MNP studies, extrapolation to environmental exposure or in vivo brain accumulation should be made cautiously. Future studies should include lower exposure concentrations, chronic exposure designs, and biologically more complex models to improve environmental and human relevance. Second, SEM, TEM, and AFM imaging were not performed; therefore, the fluorescence, turbidity, RLS, DLS, FTIR, Raman, and docking results cannot directly define aggregate morphology or confirm mature fibril formation, fibril inhibition, or fibril disruption. Instead, the data should be interpreted as indirect evidence of Aβ–PET MNP colloidal, interfacial, and structural reorganization. Third, DLS provides apparent hydrodynamic size distributions after filtration and may be influenced by polydispersity, weak agglomeration, filtration-sensitive species, and small populations of larger scatterers. Fourth, the apparent Stern–Volmer analysis showed mixed positive and negative slopes, indicating that these values should be treated as empirical fluorescence-modulation descriptors rather than binding constants or classical quenching parameters. Fifth, sedimented material, localized precipitates, vessel-wall-bound peptide, and membrane-retained material were not independently quantified. Consequently, the relative contributions of these pathways to the late-stage decline in turbidity and RLS could not be resolved. Finally, molecular docking used a simplified PET trimer model and should be considered supportive mechanistic evidence rather than a direct representation of the full heterogeneous PET MNP surface. Despite these limitations, the study has several strengths. Consumer-derived PET MNPs were used instead of only pristine model particles, improving relevance to real-world plastic exposure scenarios. Aβ was studied at ultralow concentrations to minimize spontaneous self-aggregation and emphasize MNP-driven changes relative to time-matched controls. In addition, the study integrated complementary optical, colloidal, spectroscopic, oxidative, and computational approaches rather than relying on a single assay. The filtration/recovery assessment also helped reduce the possibility that the optical responses were caused only by residual intact PET particles, although smaller fragments or dissolved components cannot be fully excluded. Importantly, the revised interpretation avoids treating fluorescence as a classical quenching system or using indirect measurements as direct evidence of fibril morphology. Therefore, the main contribution of this study is a cautious multimethod framework showing that PET MNPs modify Aβ-associated fluorescence, colloidal stability, vibrational signatures, and oxidative potential. The findings support Aβ–PET MNP interfacial and nanoscale reorganization, while acknowledging that direct imaging is required to define morphology. Future studies should include SEM, TEM, AFM, or cryo-EM, together with fibril-sensitive assays such as ThT kinetics, circular dichroism, Congo red binding, or advanced infrared/spectroscopic imaging methods. Lower MNP concentrations, longer exposure periods, environmentally aged PET particles, and biologically complex matrices should also be evaluated. Combining direct imaging, fibril-sensitive probes, and cell-based readouts would help determine whether the observed colloidal and spectroscopic changes translate into biologically relevant amyloid misfolding, altered clearance, or oxidative cellular responses. Conclusions This study provides a multiparameter assessment of the time-dependent interaction between consumer-derived PET MNPs and Aβ under controlled in vitro conditions. PET MNP exposure produced wavelength-, dose-, concentration-, and time-dependent fluorescence modulation, while apparent Stern–Volmer-type slopes were small and bidirectional, supporting nonclassical fluorescence behavior rather than a single quenching or binding mechanism. Early increases in turbidity and RLS were compatible with the formation of light-scattering Aβ–MNP-associated colloidal assemblies. At prolonged exposure, reduced turbidity and RLS and nanoscale postfiltration DLS profiles indicated changes in the abundance or optical behavior of species remaining in the measured phase. These results are compatible with several processes, including redistribution, interfacial reorganization, sedimentation, localized precipitation, vessel-wall adsorption, filtration-sensitive loss, and altered scattering efficiency. Because these alternatives were not independently quantified and direct morphological imaging was not performed, the results do not demonstrate physical compaction or a defined aggregate morphology. FTIR and Raman analyses further indicated changes in amide, C–O/C–H, and aromatic-residue-associated vibrational environments, while DTT results showed modest but measurable enhancement of cell-free oxidative potential. Molecular docking supported the possibility of PET–Aβ interfacial contacts involving aromatic and polar residues, providing a plausible molecular basis for the observed spectroscopic and colloidal responses. Overall, PET MNPs acted as time-dependent modulators of Aβ-associated fluorescence, colloidal behavior, vibrational signatures, and cell-free oxidative potential. The integrated findings support an early phase characterized by increased optical scattering and possible Aβ–PET association, followed by later changes in the nanoscale, spectroscopic, and optical characteristics of the measured phase. Because sedimentation, localized precipitation, vessel-wall adsorption, and filtration-sensitive losses were not independently quantified, and SEM, TEM, or AFM imaging was not performed, the findings should be interpreted as indirect biophysical, spectroscopic, and computational evidence of Aβ–PET MNP interaction rather than direct confirmation of physical compaction, mature fibril formation, fibril inhibition, fibril disruption, or any other defined aggregate morphology. Supplementary Material